Stock Track | WuXi AppTec Plummets 5.03% Intraday on US-UK Business Exit Amid Biosecure Act Pressure-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
2
Favorite

Stock Track | WuXi AppTec Plummets 5.03% Intraday on US-UK Business Exit Amid Biosecure Act Pressure

Stock Track05-14 11:19

WuXi AppTec's stock plummeted 5.03% during intraday trading on Thursday, reflecting significant investor concern over recent strategic moves by the company.

The sharp decline follows the company's announcement that it is transferring controlling interest in its WuXi ATU operations in the United States and United Kingdom, effectively exiting the US-UK cell and gene therapy market. This move is widely viewed as a strategic divestment of politically sensitive businesses amid ongoing pressure from the US Biosecure Act, which seeks to restrict American companies from collaborating with designated Chinese biotech firms including WuXi AppTec.

Adding to the negative sentiment, the cell and gene therapy unit had seen its gross profit losses widen by 2.4 times, providing financial rationale for the divestiture. Market sentiment was further dampened by a recent block trade showing net institutional selling of approximately 60.52 million yuan and broader weakness in the Life Sciences Tools and Services sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment（2）

非洲蛤蛤
·05-14 13:53
24年的消息還拿出來說是不是弱智
Reply
1
Report
badumdum
·05-14 13:24
Which fella wrote this? He should be removed for spreading FUD over old information
Reply
2
Report

Most Discussed

7x24

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1157168063?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 11:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157168063","market":"us","top_or_hot":-1,"title":"Stock Track | WuXi AppTec Plummets 5.03% Intraday on US-UK Business Exit Amid Biosecure Act Pressure","media":"Stock Track","content":"<p>WuXi AppTec's stock plummeted 5.03% during intraday trading on Thursday, reflecting significant investor concern over recent strategic moves by the company.</p><p>The sharp decline follows the company's announcement that it is transferring controlling interest in its WuXi ATU operations in the United States and United Kingdom, effectively exiting the US-UK cell and gene therapy market. This move is widely viewed as a strategic divestment of politically sensitive businesses amid ongoing pressure from the US Biosecure Act, which seeks to restrict American companies from collaborating with designated Chinese biotech firms including WuXi AppTec.</p><p>Adding to the negative sentiment, the cell and gene therapy unit had seen its gross profit losses widen by 2.4 times, providing financial rationale for the divestiture. Market sentiment was further dampened by a recent block trade showing net institutional selling of approximately 60.52 million yuan and broader weakness in the Life Sciences Tools and Services sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | WuXi AppTec Plummets 5.03% Intraday on US-UK Business Exit Amid Biosecure Act Pressure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | WuXi AppTec Plummets 5.03% Intraday on US-UK Business Exit Amid Biosecure Act Pressure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-14 11:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WuXi AppTec's stock plummeted 5.03% during intraday trading on Thursday, reflecting significant investor concern over recent strategic moves by the company.</p><p>The sharp decline follows the company's announcement that it is transferring controlling interest in its WuXi ATU operations in the United States and United Kingdom, effectively exiting the US-UK cell and gene therapy market. This move is widely viewed as a strategic divestment of politically sensitive businesses amid ongoing pressure from the US Biosecure Act, which seeks to restrict American companies from collaborating with designated Chinese biotech firms including WuXi AppTec.</p><p>Adding to the negative sentiment, the cell and gene therapy unit had seen its gross profit losses widen by 2.4 times, providing financial rationale for the divestiture. Market sentiment was further dampened by a recent block trade showing net institutional selling of approximately 60.52 million yuan and broader weakness in the Life Sciences Tools and Services sector.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02359","symbol_name":"药明康德","start_time":0,"source_url":"","article_id":"1157168063","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157168063","pubTimestamp":1778728782,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"WuXi AppTec's stock plummeted 5.03% during intraday trading on Thursday, reflecting significant investor concern over recent strategic moves by the company.The sharp decline follows the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02359":"药明康德"},"translate_title":"个股追踪|生物安全法案压力下美英业务退出药明康德盘中暴跌5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02359":1},"content_text":"WuXi AppTec's stock plummeted 5.03% during intraday trading on Thursday, reflecting significant investor concern over recent strategic moves by the company.The sharp decline follows the company's announcement that it is transferring controlling interest in its WuXi ATU operations in the United States and United Kingdom, effectively exiting the US-UK cell and gene therapy market. This move is widely viewed as a strategic divestment of politically sensitive businesses amid ongoing pressure from the US Biosecure Act, which seeks to restrict American companies from collaborating with designated Chinese biotech firms including WuXi AppTec.Adding to the negative sentiment, the cell and gene therapy unit had seen its gross profit losses widen by 2.4 times, providing financial rationale for the divestiture. Market sentiment was further dampened by a recent block trade showing net institutional selling of approximately 60.52 million yuan and broader weakness in the Life Sciences Tools and Services sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[{"id":564039193502288,"gmtCreate":1778737990137,"gmtModify":1778738352097,"author":{"id":"4207303588324182","authorId":"4207303588324182","name":"非洲蛤蛤","avatar":"https://community-static.tradeup.com/news/4f74fc5948c1bc1ed9a438f2af1225d1","vip":1,"crmLevel":11,"crmLevelSwitch":0,"wearingBadges":[],"idStr":"4207303588324182","authorIdStr":"4207303588324182"},"htmlText":"24年的消息還拿出來說 是不是弱智","listText":"24年的消息還拿出來說 是不是弱智","text":"24年的消息還拿出來說 是不是弱智","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/564039193502288","repostId":1157168063,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":564031589626880,"gmtCreate":1778736245134,"gmtModify":1778736248835,"author":{"id":"3582072879359907","authorId":"3582072879359907","name":"badumdum","avatar":"https://static.tigerbbs.com/858c953c6d746cceced02c5851bce220","vip":1,"crmLevel":12,"crmLevelSwitch":0,"wearingBadges":[],"idStr":"3582072879359907","authorIdStr":"3582072879359907"},"htmlText":"Which fella wrote this? He should be removed for spreading FUD over old information","listText":"Which fella wrote this? He should be removed for spreading FUD over old information","text":"Which fella wrote this? He should be removed for spreading FUD over old information","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/564031589626880","repostId":1157168063,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":2,"repostSize":2,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}